First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial.
Minetta C LiuWolfgang JanniVassilis GeorgouliasDenise A YardleyNadia HarbeckXin WeiDesmond McGovernRobert BeckPublished in: Cancer management and research (2019)
EudraCT Number: 2013-000113-20; ClinicalTrials.gov number: NCT01881230.